On the inhibition of cytochrome P450 3A4 by structurally diversified flavonoids

被引:1
|
作者
Mitrasinovic, Petar M. [1 ]
机构
[1] Belgrade Inst Sci & Technol, Ctr Biophys & Chem Res, Belgrade 11060, Serbia
来源
关键词
CYP3A4; cytochrome P450; 3A4; enzyme; flavonoid; inhibition; QM/MM; SCCDFTB-D; DENSITY-FUNCTIONAL-THEORY; INTERACTION ENERGIES; TIGHT-BINDING; BASE-PAIRS; DISPERSION; CYP3A4; COMPLEXES; IMPLEMENTATION; SIMULATIONS; METABOLISM;
D O I
10.1080/07391102.2021.1932603
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 3A4 (CYP3A4) is the most versatile enzyme involved in drug metabolism. The timedependent inhibition of CYP3A4 by acacetin, apigenin, chrysin, and pinocembrin was experimentally detected, but not entirely elaborated so far. Thus, a two-level QM/MM (Quantum Mechanics/Molecular Mechanics) model is developed to yield insights into the receptor-flavonoid recognition at the molecular scale. Active site residues and the flavonoid are modelled using SCC-DFTB-D (QM level), while the rest of the complex is treated using AMBER force field (MM level). QM/MM binding free energies are well correlated with experimental data, indicating the largest inhibitory effect of chrysin on enzyme activity at a submicromolar concentration. Consequently, quercetin (QUE) and flavopiridol (FLP) are observed as representative examples of structurally different flavonoids. The inhibition parameters for QUE and FLP are evaluated using the well-calibrated QM/MM strategy, thereby aiding to quantitatively conceive the functional behavior of the whole family of flavonoids. A kinetic threshold for further assessment of the drug-drug interactions underlying the time-dependent inhibition of CYP3A4 by flavonoids is explored.
引用
收藏
页码:9713 / 9723
页数:11
相关论文
共 50 条
  • [1] Multivariate modeling of cytochrome P450 3A4 inhibition
    Kriegl, JM
    Eriksson, L
    Arnhold, T
    Beck, B
    Johansson, E
    Fox, T
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (05) : 451 - 463
  • [2] Inhibition of Human Cytochrome P450 3A4 by Cholesterol
    Shinkyo, Raku
    Guengerich, F. Peter
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) : 18426 - 18433
  • [3] Identifying the Common Binding Modes of Flavonoids to Cytochrome P450 3A4
    Ravichandran, Sarangan
    CHEMICAL RESEARCH IN TOXICOLOGY, 2010, 23 (01) : 276 - 277
  • [4] Structures of cytochrome P450 3A4
    Scott, EE
    Halpert, JR
    TRENDS IN BIOCHEMICAL SCIENCES, 2005, 30 (01) : 5 - 7
  • [5] Development of cytochrome P450 3A4 inhibition model.
    Arimoto, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U1019 - U1020
  • [6] QSAR modeling of in vitro inhibition of cytochrome P450 3A4*
    Mao, Boryeu
    Gozalbes, Rafael
    Barbosa, Frederique
    Migeon, Jacques
    Merrick, Sandra
    Kamm, Kelly
    Wong, Eric
    Costales, Chester
    Shi, Wei
    Wu, Cheryl
    Froloff, Nicolas
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (05) : 2125 - 2134
  • [7] Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel
    Engels, FK
    ten Tije, AJ
    Baker, SD
    Lee, CKK
    Loos, WJ
    Vulto, AG
    Verweij, J
    Sparreboom, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (05) : 448 - 454
  • [8] Molecular modeling of cytochrome P450 3A4
    Szklarz, GD
    Halpert, JR
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1997, 11 (03) : 265 - 272
  • [9] RELATIONSHIP OF PASSIVE PERMEABILITY AND CYTOCHROME P450 (CYP) 3A4 INHIBITION
    Li, Ling
    Zhou, Julia
    Nouraldeen, Amr
    Wilson, Alan G. E.
    DRUG METABOLISM REVIEWS, 2014, 45 : 131 - 131
  • [10] In Vitro Inhibition of Cytochrome P450 3A4 by Aronia melanocarpa Constituents
    Braunlich, Marie
    Christensen, Hege
    Johannesen, Siri
    Slimestad, Rune
    Wangensteen, Helle
    Malterud, Karl E.
    Barsett, Hilde
    PLANTA MEDICA, 2013, 79 (02) : 137 - 141